The independent source for health policy research, polling, and news.
581-600 of 1,318 results
Covid-19, distrust of police and cheap narcotics have turned parts of the wealthy city into cesspools of filth and drug overdose. City officials and residents profoundly disagree on what needs to be done.
KHN Editor-in-Chief Elisabeth Rosenthal discusses the bottlenecks in distributing covid vaccines on NPR's āOn My Mindā podcast with host Diane Rehm.
Most private insurance will be required to cover drugs, like Truvada, that offer protection against HIV infection, without making plan members share the cost.
A growing body of research shows that overuse and misuse of antibiotics in childrenās hospitals is helping fuel superbugs, which typically strike frail seniors but are increasingly infecting kids. And the pandemic is making things worse.
While many private insurers cap what members pay in health costs, Medicare does not. Democrats and Republicans in Congress have proposed annual limits ranging from $2,000 to $3,100. But thereās disagreement about how to pay for that cost cap.
There are already signs that the distribution of the COVID vaccines will be messy, confusing and chaotic.
The coronavirus pandemic colored just about everything in 2020. But there was other health policy news that you either never heard or might have forgotten about: the Affordable Care Act going before the Supreme Court with its survival on the line; ditto for Medicaid work requirements. And a surprise ending to the āsurprise billā saga. Joanne Kenen of Politico, Anna Edney of Bloomberg News and Sarah Karlin-Smith of Pink Sheet join KHNās Julie Rovner to discuss these issues and more.
Months before federal officials authorized experimental vaccines to ward off the coronavirus in humans, scientists tried a veterinary vaccine in endangered ferrets. Drugmakers are researching similar efforts for other animals proving vulnerable to the virus, such as farmed minks, in part to guard against virus mutations that could pose new risks to people.
After missteps in Washington, each state and county is left to juggle where to send vaccines first and how to get them to each nursing home, hospital local health department and even school.
Hospitals and nursing homes must decide who gets the initial doses as the U.S. heads into the biggest vaccination effort in history. Thereās a lot left to figure out.
Everyone ā from toilet paper manufacturers to patient advocates ā is lobbying state advisory boards, arguing their members are essential, vulnerable or both ā and, thus, most deserving of an early vaccine.
With two vaccines against coronavirus disease poised for release within weeks, experts say they expect attitudes to shift dramatically from hesitancy to āBeanie Babyā-level urgency.
Fears over COVID-19 have contributed to a slump in inoculations among children. Now the federal government is looking to pharmacists for help, but many of them do not participate in a program that offers free shots to half the kids in the U.S.
COVID-19ās ālong haulersā ā patients with lingering effects of the disease ā have joined the ranks of Americans with preexisting conditions. For those shopping for health coverage on the individual market, hereās help navigating an uncharted insurance landscape.
Widespread COVID testing has revealed uncomfortable truths about medical tests: A test result is rarely a definitive answer, but instead a single clue. A result may be falsely positive or negative, or it may show an abnormality that doesnāt matter. And as COVID testing has made too clear, even an accurate, meaningful result is useless unless itās acted on appropriately.
A Trump administration maneuver allows executives who are leading the federal effort to keep investments in drug companies that would benefit from the pandemic response.
A proposal in Washington state would use right-to-try laws to allow terminally ill patients access to psilocybin ā the famed magic mushrooms of Americaās psychedelic ā60s ā to ease depression and anxiety.
A provision the Trump administration tucked into its final rule on health plan price transparency requires telling consumers what they will pay out-of-pocket for drugs and showing them what the plan paid.
Drugmakers will walk away with massive profits, but much of the pioneering work on mRNA vaccines was done with government money.
The tax was touted as a way to generate funding for treatment programs across the state. But to avoid paying, scores of manufacturers and wholesalers stopped selling opioids in New York.
Ā© 2026 KFF